Russian MedicineRussian MedicineРоссийский медицинский журнал0869-21062412-9100Eco-Vector3847310.18821/0869-2106-2018-24-3-157-162ArticlesСтатьиReview ArticleTHE BIPOLAR AFFECTIVE DISORDER TYPE IIБИПОЛЯРНОЕ АФФЕКТИВНОЕ РАССТРОЙСТВО II ТИПАBardenshteynLeonid M.БарденштейнЛеонид Михайлович

doctor of medical sciences, the head of the Chair of Psychiatry and Narcology «The A.E. Evdokimov Moscow State University of Medicine and Dentistry», 127473, Moscow, Russian Federation

доктор мед. наук, зав. кафедрой психиатрии и наркологии ФГБОУ ВО «Московский государственный медико-стоматологический университет имени А.И. Евдокимова» Министерства здравоохранения РФ, 127473, Москва

barden@mail.ruOsipovaN. NОсиповаН. НSlavgorodskyYa. MСлавгородскийЯ. МBeglyankinN. IБеглянкинН. ИAleshkinaG. AАлешкинаГ. АTuranskyM. MТуранскийМ. М«The A.E. Evdokimov Moscow State University of Medicine and Dentistry»ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Министерства здравоохранения РФ«The Smolensk State Medical University» of the Ministry of Health of the Russian FederationФГБОУ ВО «Смоленский государственный медицинский университет» Минздрава России15062018243VOL 24, NO3 (2018)ТОМ 24, №3 (2018)15716221072020Copyright ©; 2018, Eco-VectorCopyright ©; 2018, ООО "Эко-Вектор"2018Eco-VectorООО "Эко-Вектор"https://medjrf.com/0869-2106/article/view/38473

The article presents review of modern publications concerning studies of bipolar affective disorder type II. The materials are summing up concerning national and international studies of characteristics of clinical course of depressions and hypo-maniacal states within the framework of bipolar affective disorder type II, problems of differential diagnostic of bipolar affective disorder within spectrum of affective pathology. The significance of studying of pre-morbid background in case of bipolar affective disorder type II, co-morbid states for prognosis of course of disease is demonstrated. The screening, diagnostic and estimated scales and questionnaires are considered including principles of their application as an add-on to actual international diagnostic systems ICD-10, DSM-IV-TR, DSM-V.

В статье представлен обзор современной литературы, посвящённой изучению биполярного аффективного расстройства II типа (БАР II). Обобщаются материалы отечественных и зарубежных исследований по особенностям клинического течения депрессий и гипоманиакальных состояний в рамках БАР II, проблемы дифференциальной диагностики биполярного аффективного расстройства в спектре аффективной патологии. Показана значимость изучения преморбидного фона при БАР II, коморбидных состояний для прогнозирования течения заболевания. Рассмотрены скрининговые, диагностические и оценочные шкалы, опросники и принципы их использования в качестве дополнения к современным международным диагностическим системам МКБ-10 и DSM-IV-TR, DSM-V.

DSM-IV-TRDSM-Vreviewbipolar affective disorder type IIICD-10DSM-IV-TRDSM-Vdiagnosticscreening toolquestionnaireобзорбиполярное аффективное расстройство II типаМКБ-10диагностикаскрининговый инструментопросникKawa I., Carter J.D., Joyce P.R., Doughty C.J., Frampton C.M., Wells J.E. et al. Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation. Bipolar. Disord. 2005; 7(2): 119-25.Alonso J., Angermeyer M. C., Bernert, S., Bruffaerts R., Brugha T.S., Bryson H. et al. Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica. 2004; 109(420): 8-20.Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994; 51(1): 8-19.Мосолов С.Н., Ушкалова А.В., Костюкова Е.Г., Шафаренко А.А., Алфимов П.В., Костюкова А.Б. Диагностика биполярного аффективного расстройства II типа среди пациентов с текущим диагнозом рекуррентного депрессивного расстройства. Современная терапия психических расстройств. 2014; (2): 2-14MacQueen G.M., Young L.T. Bipolar II Disorder: symptoms, course and response to treatment. Psychiatr. Serv. 2001; 52(3): 358-61.Viguera A.C, Baldessarini R.J., Tondo L. Response to lithium maintenance treatment in bipolar disorders: comparison of men and women. Bipolar. Disord. 2001; 3(5): 245-52.Baldessarini R.J., Bolzani L., Cruz N. Onset-age of bipolar disorders at six international sites. J. Affect. Dis. 2010; 121(1-2): 143-6.Brugue E., Colom F., Sanchez-Moreno J., Cruz N., Vieta E. Depression subtypes in bipolar I and II disorders. Psychopathology. 2008; 41(2): 111-4.Benazzi F. Bipolar II disorder: epidemiology, diagnosis and management. CNS Drugs. 2007; 21(9): 727-40.Wilde A., Chan H.N., Rahman B., Meiser B., Mitchell P.B., Schofield P.R. et al. A meta-analysis of the risk of major affective disorder in relatives of individuals affected by major depressive disorder or bipolar disorder. J. Affect. Disord. 2014; 158: 37-47.Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh: E.&S. Livingstone; 1921.Dunner D.L., Stallone F., Fieve R.R. Lithium carbonate and affective disorders. V. A double-blind study of prophylaxis of depression in bipolar illness. Arch. Gen. Psychiatry. 1976; 33: 117-20.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III). Washington, DC: American Psychiatric Association; 1982.American Psychiatric Association. «Diagnostic and Statistical Manual of Mental Disorders» (DSM-IV). Washington, DC: American Psychiatric Association; 2000.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 2013.Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry. 1978; 133: 429-35.Akiskal H.S., Pinto O. The evolving bipolar spectrum: prototypes I, II, III, and IV. Psychiatr. Clin. North Am. 1999; 22(3): 517-34.Judd L.L, Akiskal H.S. Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder. Curr. Psychiatry Rep. 2003; 5(6): 417-18.McIntyre R.S. Improving the early recognition and diagnosis of bipolar disorder. J. Clin. Psychiatry. 2014; 75(2): 103-10.Baldessarini R.J., Tondo L., Visioli C. First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr. Scand. 2014; 129(5): 383-92.Ostacoli L., Zuffranieri M., Cavallo M., Zennaro A., Rainero I., Pinessi L. et al. Age of Onset of Mood Disorders and Complexity of Personality Traits. ISRN Psychiatry. 2013; 2013: 246358.Барденштейн Л.М., Славгородский Я.М. Место биполярной депрессии в современных классификациях болезней и проблема ее распознавания. Психическое здоровье. 2013; 11(7): 27-30.Барденштейн Л.М. Биполярное аффективное расстройство. Российский медицинский журнал. 2009; 15(2): 50-3.Coryell W., Fiedorowicz J., Leon A.C., Endicott J., Keller M.B. Age of onset and the prospectively observed course of illness in bipolar disorder. J. Affect. Disord. 2013; 146(1): 34-8.Suppes T., Leverich G.S., Keck P.E., Nolen W.A., Denicoff K.D., Altshuler L.L. et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J. Affect. Disord. 2001; 67(1-3): 45-59.Himmelhoch J.M. Social anxiety, hypomania, and the bipolar spectrum: data, theory, and clinical issues. Journal of Affective Disorders. 1998; 50(2-3): 203-13.Костюкова Е.Г., Мосолов С.Н. Принципы и инструменты диагностики биполярного аффективного расстройства как основа рациональной фармакотерапии. Современная терапия психических расстройств. 2015; (2): 2-10.Мосолов С.Н., Ушкалова А.В., Костюкова Е.Г., Шафаренко А.А., Алфимов П.В., Костюкова А.Б. Формализованная диагностика биполярного аффективного расстройства у больных с приступообразной шизофренией и шизоаффективным расстройством. Современная терапия психических расстройств. 2014; (3): 2-7.Зражевская И.М. Биполярное аффективное расстройство (клинико-динамические, клинико-прогностические закономерности и аспекты психофармакотерапии): Автореф. дисс. … д-ра мед. наук. Томск; 2010.Swann A.C., Lijffijt M., Lane S.D., Steinberg J.L., Moeller F.G. Interactions between bipolar disorder and antisocial personality disorder in trait impulsivity and severity of illness. Acta Psychiatr. Scand. 2010; 121(6): 453-61.Sharma V., Burt V.K. DSM-V: modifying the postpartum-onset specifier to include hypomania. Arch. Women’s Ment. Health. 2011; 14(1): 67-9.Carlson G.A., Blader J.C. Diagnostic implications of informant disagreement for manic symptoms. J. Child. Adolesc. Psychopharmaco. 2011; 21(5): 399-405.Смулевич А.Б. Психопатология личности и коморбидных расстройств: Учебное пособие. М.: Медпресс-информ; 2009Akiskal H.S., Kilzieh N, Maser J.D., Clayton P.J., Schettler P.J., Traci Shea M. et al. The distinct temperament profiles of bipolar I, bipolar II and unipolar patients. J. Affect. Disord. 2006; 92(1): 19-33.Grilo C.M. Personality disorders predict relapse after remission from an episode of major depressive disorder: a 6-year prospective study. J. Clin. Psychiatr. 2010; 71(12): 1629-35.Amerio A., Odone A., Liapis C.C., Ghaemi S.N. Diagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review. Acta Psychiatr. Scand. 2014; 129(5): 343-58.Calkin C.V., Gardner D.M., Ransom T., Alda M. The relationship between bipolar disorder and type 2 diabetes: More than just co-morbid disorders. Ann. Med. 2013; 45(2): 171-81.Laursen T.M., Munk-Olsen T., Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011; 6(9): e24597Bulik C.M., Carpenter L.L., Kupfer D.J. et al. Features associated with suicide attempts in recurrent major depression. J. Affect. Disord. 1990; 18(1): 29-37.Ghaemi S.N., Bohman E.E., Goodwin F.K. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J. Clin. Psychiatr. 2000; 61(10): 804-8.Kemp D.E., Sylvia L.G., Calabrese J.R., Nierenberg A.A., Thase M.E., Reilly-Harrington N.A. et al. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr. Scand. 2013; 129(1): 24-34.Hirschfeld R.M., Cass A.R., Holt D.C.L., Carlson C.A. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J. Am. Board Fam. Pract. 2005; 18(4): 233-9.Angst J., Adolfsson R., Bennazzi F., Gamma A., Hantouche E., Meyer T.D. et al. The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients. J. Affect. Dis. 2005; 88(22): 217-33.Akiskal H.S., Benazzi F. Optimizing the detection of bipolar II disorder in outpatient private practice: toward a systematization of clinical diagnostic wisdom. J. Clin. Psychiatry. 2005; 66(7): 914-21.Akiskal H.S. Switching from “unipolar” to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch. Gen. Psychiatry. 1995; 52: 114-23.Hirschfeld R.M.A., Williams J.B., Spitzer R.L., Calabrese J.R., Flynn L., Keck P.E. et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am. J. Psychiatry. 2000; 157(11): 1873-5.Vázquez G.H., Romero E., Fabregues F., Pies R., Ghaemi N., Mota-Castillo М. Screening for bipolar disorders in Spanish-speaking populations: Sensitivity and specificity of the Bipolar Spectrum Diagnostic Scale-Spanish Version. Compr. Psychiatry. 2010; 51(5): 552-6.